Küçükyurt Kaya S, Koca O, Aydın Kaynar L, et al. Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors. Acta Medica. 2026;57(2):157-165. https://doi.org/10.32552/actamedica.2026.1271